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Abstract
The general paradigm that emerges from the analysis of the transcriptome of the malaria parasite
Plasmodium falciparum is that the expression clusters of genes that code for enzymes engaged in the
same cellular function is coordinated. Here the consistency of this perception is examined by
analysing specific pathways that metabolically-linked. The pentose phosphate pathway (PPP) is a
fundamental element of cell biochemistry since it is the major pathway for the recycling of NADP+
to NADPH and for the production of ribose-5-phosphate that is needed for the synthesis of
nucleotides. The function of PPP depends on the synthesis of NADP+ and thiamine pyrophosphate,
a co-enzyme of the PPP enzyme transketolase. In this essay, the transcription of gene coding for
enzymes involved in the PPP, thiamine and NAD(P)+ syntheses are analysed. The genes coding for
two essential enzymes in these pathways, transaldolase and NAD+ kinase could not be found in the
genome of P. falciparum. It is found that the transcription of the genes of each pathway is not always
coordinated and there is usually a gene whose transcription sets the latest time for the full
deployment of the pathway's activity. The activity of PPP seems to involve only the oxidative arm
of PPP that is geared for maximal NADP+ reduction and ribose-5-phosphate production during the
early stages of parasite development. The synthesis of thiamine diphosphate is predicted to occur
much later than the expression of transketolase. Later in the parasite cycle, the non-oxidative arm
of PPP that can use fructose-6-phosphate and glyceraldehyde-3-phosphate supplied by glycolysis,
becomes fully deployed allowing to maximize the production of ribose-5-phosphate. These
discrepancies require direct biochemical investigations to test the activities of the various enzymes
in the developing parasite. Notably, several transcripts of PPP enzyme-coding genes display biphasic
pattern of transcription unlike most transcripts that peak only once during the parasite cycle. The
physiological meaning of this pattern requires further investigation.
Introduction
The analysis of the transcriptome of Plasmodium falci-
parum has revealed that during the intraerythrocytic devel-
opment of the parasite, genes coding for enzymes and
proteins that are involved in complex cellular functions
such as transcription, replication or energy metabolism,
each involving many gene products, are transcribed in a
coordinated fashion, supporting the notion that all com-
ponents must be present at the right time to allow for opti-
mal function [1-3]. While this may be true in general, it
has already been found that scrutinizing the details of spe-
cific metabolic functions reveal some significant
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departures from this paradigm [4]. Such scrutiny has also
provided some intriguing peculiarities that through
detailed biochemical studies may reveal some parasite-
specific functions that may enlighten our understanding
of parasitism or even provide for novel targets for chemo-
therapeutic intervention. The present analysis explores of
the transcriptome to fathom additional metabolic
pathways.
During the erythrocytic stage the malaria parasite is
engaged in intensive synthesis of nucleotides and is sub-
jected to endogenously produced oxidative radicals that
must be detoxified. Like other cells, in order to perform its
anabolism, the parasite needs not only energy (ATP): it
also needs reducing power, under the form of NADPH.
Enzymes that function primarily in the reductive direction
utilize NADP+/NADPH pair as co-factors as opposed to
oxidative enzymes that utilize the NAD+/NADH cofactor
pair. The conversion of ribonucleotides to deoxyribonu-
cleotides (through the action of ribonucleotide reductase)
requires NADPH as the electron source. Thus, any cell that
proliferates rapidly requires large quantities of NADPH.
NADPH can be produced during glucose-6-phosphate
oxidation through the pentose-phosphate pathway (PPP;
Figure 1). This pathway also produces ribose-5-phosphate
(R5P), the sugar component of nucleic acids.
The reactions of the PPP operate exclusively in the cyto-
plasm. PPP has both an oxidative and a non-oxidative
arm. The oxidation steps, utilizing glucose-6-phosphate
(G6P) as the substrate, occur at the beginning of the path-
way and are the reactions that generate NADPH. Thus, the
first carbon of glucose-6-phosphate is first oxidized to a
lactone (catalyzed by glucose-6-phosphate dehydroge-
nase) concomitantly releasing two electrons that reduce
one molecule of NADP+ to NADPH. The ensuing decar-
boxylation of 6-phospho-D-gluconate (catalyzed by 6-
phosphogluconate dehydrogenase) releases two addi-
tional electrons, which reduce a second molecule of
NADP+. A five-carbon sugar, D-ribulose-5-phosphate, is
produced in the reaction. By isomerization, D-ribulose-5-
phosphate is transformed into D-ribose-5-phosphate
(R5P). To be used in nucleic acid synthesis, R5P is trans-
formed into 5-Phospho-?-D-ribose 1-pyrophosphoric
acid (PRPP) by ribose-phosphate diphosphokinase (EC:
2.7.6.1).
The non-oxidative reactions of the PPP are primarily
designed to generate R5P. Equally important reactions of
the PPP are to convert dietary 5 carbon sugars or D-ribose-
1-phosphate generated in the salvage of purines (that can
be slowly converted to R5P by phosphoglucomutase; EC:
5.4.2.2) into both 6 (fructose-6-phosphate) and 3 (glycer-
aldehyde-3-phosphate) carbon sugars which can then be
utilized by the pathways of glycolysis. In the first reaction,
R5P will accept two carbon atoms from xylulose-5-phos-
phate (obtained by epimerization of ribulose-5-P), yield-
ing sedoheptulose-7-phosphate and glyceraldehyde-3-
phosphate (catalyzed by transketolase). Sedoheptulose-7-
phosphate transfers three carbons to glyceraldehyde-3-
phosphate (catalyzed by transaldolase), yielding fructose-
6-phosphate (F6P) and erythrose-4-phosphate. Erythrose-
4-phosphate then accepts two carbon atoms from a sec-
ond molecule of xylulose-5-phosphate (catalyzed again
by transketolase), yielding a second molecule of F6P and
a glyceraldehyde-3-P (GAP) molecule. F6P and a GAP can
then enter glycolysis and eventually produce ATP. The
intermediate erythrose-4-phosphate is a substrate for the
shikimate pathway http://sites.huji.ac.il/malaria/maps/
shikimatebiopath.html.
The non-oxidative part of PPP can also work in the reverse
direction utilizing fructose-6-phosphate glyceraldehyde-
3-phosphate generated by glycolysis to produce ribose-5-
phosphate. In essence, the PPP can operate in different
modes (Figure 2). When both R5P and NADPH are
needed (Figure 2 mode 1) only the oxidative path will
operate: all the ribulose 5-phosphate is isomerized to R5P
and the pathway is completed. When more ribose-5-phos-
phate than NADPH is needed (Figure 2 mode 2), R5P is
synthesized by a reversion of the non-oxidative path from
F6P and GAP generated by glycolysis. When the cell needs
both NADPH and ATP but not R5P (Figure 2 mode 3): rib-
ulose-5-phosphate is converted to F6P and GAP for glyco-
lysis to make ATP and NADH.
The genes that code for enzymes participating in ancillary
processes that produce NADP+ and thiamine pyrophos-
phate, that serves as a co-factor for transketolase activity,
should be expressed in coordination with the enzymes of
the PPP. The details of the mentioned pathways can be
also grasped at (http://sites.huji.ac.il/malaria/maps/nico
tinatemetpath.html; http://sites.huji.ac.il/malaria/maps/
thiaminemetpath.html, respectively) and the time-
dependent transcription of the genes coding for the differ-
ent enzymes will be discussed below.
PPP activity in P. falciparum-infected erythrocytes has been
measured [5-7]. The reverse activity of the non-oxidative
arm of PPP has also been demonstrated by measuring the
incorporation of radiolabel from [1-14C]glucose into
nucleotides [6,8]. The former investigators have shown
that 4/5 of the glucose incorporated into parasite nucleic
acids comes from the condensation of F6P and GAP in the
reverse action of this arm. Atamna et al, reported that
infected cells have large increase of PPP activity where 82
% is contributed by the parasite while the host cell's PPP
activity is activated some 24-fold as a result of the oxida-
tive stress that the parasite generates and impinges on the
host cell [9].Malaria Journal 2005, 4:17 http://www.malariajournal.com/content/4/1/17
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The gene coding for G6PD has been cloned [10] and the
biochemical properties of the isolated enzyme have been
characterized [11,12]. Molecular investigations have
revealed that G6PD is coded by a hybrid gene that con-
tains also the sequence of 6-phosphogluconolactonase
(the second enzyme of PPP) [13,14]. Activity of 6-phos-
phogluconate dehydrogenase in Plasmodium-infected
erythrocytes has been detected indirectly and alluded to a
parasite enzyme, but not characterized [15-17]. Ribose-
phosphate diphosphokinase of P. falciparum activity has
been characterized and levels of its product 5'-phosphori-
bosyl-pyrophospate (PRPP) were measured in P. falci-
parum-infectederythrocytes [8,18]. The levels of PRPP
were found to be increased 56-fold in infected cells at the
trohozoite stage compared to uninfected erythrocytes.
The parasite contains substantial levels of the pyridine
nucleotides NAD+ and NADP+ and their reduced forms
[19] and jointly with the presence of genes coding for the
enzymes necessary for their synthesis in the genome of P.
Pentose phosphate pathway Figure 1
Pentose phosphate pathway. The no-entry symbol indicates that the gene coding for this enzyme could not be found in the 
genome of P. falciparum, but biochemical evidence suggests that the enzyme activity must be present. P represents phosphate.
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falciparum (but see below the discussion concerning the
absence of NAD+ kinase-coding gene), indicate the ability
of the parasite to produce these co-factors. NADP+/
NADPH are used by several biochemical reactions in the
parasite (Table 1), but the major role of NADPH is prob-
ably in the antioxidant defense of the parasite [20,21] (see
http://sites.huji.ac.il/malaria/maps/redoxmetpath.html
for details). Interestingly enough, the biochemical (such
as the intermediate products, enzyme activities for each
step, timing of production?) details of NAD(P)+ synthesis
in the parasite such as the intermediate products, enzyme
activities for each step, timing of production, were not
investigated.
In this in silico analysis, the stage-dependent transcription
of genes that code for enzymes that are involved in the
PPP activity of the parasite will be analyzed in a functional
context.
Different modes of PPP action Figure 2
Different modes of PPP action. The PPP can function in different modes depending on the needs of the cell. Mode 1: Both 
ribose-5-phosphate and NADPH needed – predominating reactions are shown. – All the ribulose 5-phosphate is isomerized to 
ribose 5-phosphate, which is used for the synthesis of PRPP. Mode 2: More ribose-5-phosphate is needed than NADPH Ribose 
5-phosphate is synthesized by the non-oxidative arm using fructose-6-phosphate and glyceraldehydes-3-phosphate supplied by 
glycolysis. Mode 3: The cell needs NADPH and ATP but not ribose-5-phosphate. Ribulose-5-phosphate is converted to fruc-
tose-6-phosphate and glyceraldehydes-3-phosphate which are channeled into glycolysis
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Materials and methods
The expression data used in this study was obtained from
the transcriptome database http://malaria.ucsf.edu/ of the
P. falciparum intraerythrocytic developmental cycle as
described [2]. This database contains the relative mRNA
abundance for every hour of the intraerythrocytic cycle of
parasite development based on the 70-mer oligonucle-
otide microarray [22]. The expression profile of each tran-
script is represented by an array of ratios between the
mRNA level in the time point sample versus a fixed mRNA
level in the control RNA pool. Loess smoothed expression
profiles used in this study were calculated as described
(see [2]). The peak hour induction was calculated from
these profiles. This represents more accurate estimate of
Table 1: NADP utilizing enzymes Enzymes are arranged by their sequential functional order. They are given by their name, their EC 
numbers, the gene identification (PfID) in the Plasmodium genome database (PlasmoDB), the time (in hours post invasion (HPI)) in the 
parasite's developmental cycle when they are maximally transcribed obtained from the IDC database and the metabolic function of 
the enzyme.
Enzyme EC number PfID Peak (HPI) Metabolic function
3-oxoacy1-[acy1-carrier-protein] reductase 1.1.1.100 PFI1125c 28 Fatty acid synthesis
1-deoxy-D-xylulose-5-phosphate reductoisomerase 1.1.1.267 PF14_0641 30 Isoprenoid metabolism
Isocitrate dehydrogenase (NADP+); 1.1.1.42 PF13_0242 28 TCA cycle
Phosphogluconate dehydrogenase 1.1.1.44 PF14_0520 26 PPP
Glucose-6-phosphate 1-dehydrogenase; 1.1.1.49 PF14_0511 48 PPP
Pyruvate dehydrogenase (acetyltransferring). 1.2.4.1 PF11 0256 PF14 0441 28 28 Pyruvate metabolism
Glutamate dehydrogenase (NADP) 1.4.1.4 PF14 0164 PF14 0286 1 30 Glutamate metabolism
Pyrroline-5-carboxylate reductase 1.5.1.2 MAL13P1.284 18 Proline metabolism
Dihydrofolate reductase 1.5.1.3 PFD0830w 26 Folate synthesis
NAD(P)+ transhydrogenase (B-specific); 1.6.1.1 PF14_0508 32 ?
NADPH hemoprotein reductase 1.6.2.4 PFI1140w 13 Flavoprotein reduction
Dihydrolipoamide dehydrogenase 1.8.1.4 PF08 0066 PFL1550w 28 11 Pyruvate metabolism
Dihydrolipoamide S-acetyltransferase; 2.3.1.12 PF10 0407 28 Pyruvate metabolism
Table 2: Enzymes of the pentose phosphate pathway and pyridine nucleotide metabolism. Enzymes are grouped into pathways. They 
are given by their name, their EC numbers, the gene identification (PfID) in the Plasmodium genome database (PlasmoDB)), the time 
(in hours post invasion (HPI)) in the parasite's developmental cycle when they are maximally transcribed obtained from the IDC 
database and the metabolic function of the enzyme.
Pathway Enzyme EC number Pf ID Peak (HPI)
Pentose phosphate pathway Glucose-6-phosphate dehydrogenase 1.1.1.49 PF14_0511 48
6-phosphogluconolactonase 3.1.1.31 PF14 0511 48
6-phosphogluconate dehydrogenase 1.1.1.44 PF14_0520 26
Ribulose 5-phosphate 3-epimerase 5.1.3.1 PFL0960w 29
Ribose 5-phosphate isomerase 5.3.1.6 PFE0730c 21
Transketolase 2.2.1.1 MAL6P1.110 17
Ribose phosphate diphosphokinase 2.7.6.1 PF13 0143 PF13 0157 21 21
Deoxyribose phosphate aldolase 4.1.2.4 PF10 0210 21
Phosphoglucomutase 5.4.2.2 PF10 0122 21
Pyridine nucleotide metabolism Nicotinamidase 3.5.1.19 chr3.glm 243 18, 38
Nicotinatephosphoribosyl transferase 2.4.2.11 chr6.glm_337 25
Nicotinate-nucleotide adenylyl transferase 2.7.7.18 chr13.glm_329 20, 40
NAD+ synthetase 6.3.5.1 PFI1310w 28
Pyridine nucleotide transhydrogenase 1.6.1.1. PF14_0508 32
Thiamine metabolism  Hydroxyethylthiazole kinase 2.7.1.50 PFL1920c 22
Hydroxymethylpyrimidine kinase/ 
Phosphomethylpyrimidine kinase
2.7.149 2.7.4.7 PFE1030c 33
Thiamine-phosphate diphosphorylase 2.5.1.3 MAL6P1.285 1
Thiamine diphosphokinase 2.7.6.2 PFI1195c 28Malaria Journal 2005, 4:17 http://www.malariajournal.com/content/4/1/17
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the timing of maximal expression since the loess smooth-
ing provides and average mRNA abundance values over a
time interval, correcting possible minor fluctuations in
the raw value profiles. Each expression profile was subse-
quently normalized by its peak value. It is assumed that
for each metabolic pathway there is a stoichiometric rela-
tionship between its individual enzymes and therefore the
normalized values are more meaningful for functional
evaluation. All enzymes discussed in this essay with their
EC numbers and gene ID's are shown in Table 2. Amplifi-
cation of transcription was calculated by dividing the
maximum value by the minimum value of the profile of
relative mRNA abundance. A fair agreement between the
time-dependent transcription data of the DeRisi transcrip-
tome and Winzeler's data has been observed (data not
shown).
Results and Discussion
At the onset of the present analysis, it should be under-
scored that time-dependent transcription does not always
overlaps translation. Hence, transcript levels cannot be
directly extrapolated to levels of their translated product.
Moreover, transient transcription does not divulge on the
stability of the translated products. Indeed, a recent anal-
ysis has shown for several genes that while the transcript
peaks at the trophozoite stage and declines thereafter, the
translated protein continues to accumulate [23].
Significant discrepancies between mRNA and protein
abundance in P. falciparum were also reported by LeRoche
et al. [24]. This was shown to be due to a delay between
the maximum detection of an mRNA transcript and that
of its cognate protein. Surely, a protein cannot be
produced if its cognate gene is not transcribed. Therefore,
the present analysis can at best set a time for possible
translation but not for its actual occurrence. Thus, while
transcript levels are informative for the concerted action
of metabolically related enzymes, post-transcriptional
mechanisms for controlling protein levels and protein sta-
bility must also be considered.
In this analysis, the transcription of genes coding for
enzymes that constitute the PPP will be discussed first
followed by those that are involved in the synthesis of
NAD(P)+ and of thiamine pyrophosphate.
The pentose phosphate pathway
The pathway is shown in Figure 1 and the time-dependent
transcription of the different genes is depicted in Figure 3.
Whereas G6PD (EC: 1.1.1.49) and hence its conjoint 6-
phosphogluconolactonase (EC: 3.1.1.31) are transcribed
at high levels during the early stages of parasite develop-
ment, the transcription of 6-phosphogluconate dehydro-
genase (EC: 1.1.1.44) seems to be biphasic (first peak at 9
hours post invasion (HPI) while the major peak is
observed at 26 HPI). The two other enzymes that need to
be present for full synthesis of PRPP are ribose phosphate
isomerase (EC: 5.3.1.6) and ribose-phosphate diphos-
phokinase (EC: 2.7.6.1). The first has a small peak at 12
HPI and a major one at 21 HPI. The parasite contains 2
genes that code for ribose-phosphate diphosphokinase
(PF13_0143 and PF13_0157). Both peak at 21 HPI. Thus,
the oxidative arm seems to be fully activated to meet the
requirement of ribonucleotide synthesis according to
mode 1 of Figure 2. The genes that code for this process
are coordinately transcribed starting immediately after
invasion and peak at 12 HPI [2]. Biochemical evidence
indicates that ribonucleotide synthesis starts at the mature
ring stage [25]. Functioning according to mode 1 (Figure
2) would also supply reducing power to neutralize the
toxic reactive oxidative species that are maximally pro-
duced during the hemoglobin-rich cytosol of the host cell
[9]. It seems that the synthesis of PRPP and its utilization
in the synthesis purine and pyrimidine nucleotides serves
as a metabolic sink that could accelerate the pace of the
oxidative arm. Contrary to this judicious coordination,
the transcription of genes coding for enzymes needed for
the synthesis of NADP+ that is essential for the operation
Time dependent transcription of genes coding for enzymes  involved in the pentose phosphate pathway Figure 3
Time dependent transcription of genes coding for 
enzymes involved in the pentose phosphate pathway. 
Glucose-6-phosphate dehydrogenase/6-phosphogluconolac-
toase – black filled circles; 6-phosphogluconate dehydroge-
nase – red filled circles; Ribose phosphate isomerase – blue 
filled circles; Ribulose 5-phosphate epimerase – green filled 
circles. Transketolase – purple filled circles; Ribose phos-
phate diphosphokinase (PF13_0157) – gold filled circles and 
(PF13_0143) – dark green filled circles. Glucose-6-phosphate 
dehydrogenase and 6-phosphogluconolactoase were grouped 
together because they constitute a chimerical protein.
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of the oxidative arm, lags considerably behind (see
below). This is a crucial paradox that waits to be resolved.
The situation of the non-oxidative arm genes is different.
The gene that codes for ribose phosphate isomerase (EC:
5.1.3.1) peaks at 21 HPI and this seems to restrict the
expression of the non-oxidative arm, since transketolase
(EC: 2.2.1.1) is transcribed maximally immediately fol-
lowing invasion. Most importantly, the gene that codes
for transaldolase (EC: 2.2.1.2) could not be found in the
genome of P. falciparum (or in any other Plasmodium spe-
cies sequenced so far, or in any other Apicomplexans for
that matter) thus precluding the completion of the analy-
sis of the non-oxidative arm transcription. As mentioned
above, biochemical evidence indicates that this arm is
active in the parasite. If it is indeed fully activated when
ribose phosphate isomerase is transcribed (and supported
by the transcription of the genes that code for ribose-
phosphate diphosphokinase that peak at 21 HPI), it
would match the transcription of the deoxyribonucleotide
synthesis-related genes that starts at 18 HPI and peaks at
30 HPI [2] as well as those related to NADP+ synthesis.
When the synthesis of ribonucleotides and deoxyribonu-
cleotides ebbs off towards the end of the intraerythrocytic
life cycle of the parasite, the PPP probably functions
according to mode 3 (Figure 2) providing both NADPH
and ATP. A feature that emerges from this analysis is that
the transcription of the genes that code for enzymes acting
in the non-oxidative arm are coordinated as shown for
other clusters of genes whose products are functionally
related [1-3]. However, it remains to be seen if the cognate
enzymes of these transcripts are similarly coordinated
since significant discrepancies between mRNA and pro-
tein abundance has been recently reported [24].
NAD(P) biosynthesis
The pathway is shown in Figure 4 and the time-dependent
transcription of the different genes is depicted in Figure 5.
Nicotine adenine dinucleotide (NAD+) and NAD phos-
phate (NADP+) play key roles in glycolysis and PPP as well
as many other enzymatic reactions (see Tables 3 and 1,
respectively). NAD synthesis starts by converting nicotinic
acid to nicotinate D-ribonucleotide by nicotinate phos-
phoribosyltransferase (NAPRT; EC: 2.4.2.11). Nicotinate
D-ribonucleotide is then adenylated to deamino-NAD+ in
a reaction catalyzed by nicotinate-nucleotide adenylyl-
transferase (EC: 2.7.7.18) then this intermediate is ami-
dated to NAD+  by NAD synthetase (EC: 6.3.5.1).
Nicotinamide can be used for NAD synthesis either by
being deamidated to nicotininc acid by nicotinamidase
(EC: 3.5.1.19) or by being converted to nicotinamide
mononucleotide by nicotinamide phosphoribosyltrans-
ferase (NPRT; EC: 2.4.2.12) and then to NAD by NAD
pyrophosphorylase (EC: 2.7.7.1). Genes coding for the
two latter enzymes could not be found in the genome of
Nicotine nucleotide metabolism Figure 4
Nicotine nucleotide metabolism. The no-entry symbol indicates that the gene coding for this enzyme could not be found 
in the genome of P. falciparum, but biochemical evidence suggests that the enzyme activity must be present.
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P. falciparum, although a measurable activity of NPRT has
been detected [26]. These enzymes are present in normal
erythrocytes and at physiological conditions the produc-
tion of NAD+ from nicotinamide seems to be more impor-
tant than that of NADP+  [27]. Zerez et al. [26]
demonstrated 15-fold increase in the levels of NAD+
(NAD+ + NADH) in P. falciparum-infected erythrocytes, as
well as 3-fold increase in NAPRT activity. These results
indicate that the parasite is capable of NAD synthesis
although neither the activity of nicotinate-nucleotide ade-
nylyltransferase or of NAD synthetase were increased in
infected cells compared to uninfected erythrocytes. This
observation suggests that these enzymes must be active in
the parasite since the digestion of host cell cytosol during
parasite development should have reduced their activities.
Abundant nicotinamidase activity was also detected in
infected cells implying that the parasite can synthesize
NAD+ from both nicotinic acid and nicotinamide (both
present in RPMI-1640 medium used for parasite cultiva-
tion). The concentrations of NADP+ in infected cells are
10-fold lower that those of NAD+. A gene coding for NAD+
kinase could not be found in the genome of P. falciparum
or in any other Plasmodium species or in other Apicompl-
exans, but could be detected in Giardia lamblia. No
information about the action of NAD kinase in the para-
site could be found.
Time dependent transcription of genes coding for enzymes  involved in the biosynthesis of NAD(P)+ Figure 5
Time dependent transcription of genes coding for 
enzymes involved in the biosynthesis of NAD(P)+. 
Nicotinamidase – purple filled circles; Nicotinate phosphori-
bosyl transferase – green filled circles; Nicotinate-nucleotide 
adenylyltransferase – red filled circles; NAD+ synthetase – 
black filled circles; NAD(P) transhydrogenase – blue filled 
circles.
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Table 3: NAD+-utilizing enzymes. Enzymes are arranged by their sequential functional order. They are given by their name, their EC 
numbers, the gene identification (PfID) in the Plasmodium genome database (PlasmoDB), the time (in hours post invasion (HPI)) in the 
parasite's developmental cycle when they are maximally transcribed obtained from the IDC database, the metabolic function of the 
enzyme.
Enzyme EC number PfID Peak (HPI) Metabolic function
Pyrroline carboxylate reductase 1.5.1.2 MAL13P1.284 18 Methionine polyamine metabolism
Ferrodoxin reductase-like protein 1.7.1.4 PF07_0085 21 Nitrogen metabolism
Glutamate dehydrogenase 1.4.1.2 PF08_0132 20 Glutamine metabolism
Aminomethyltransferase 2.1.2.10 PF13 0345 22 Folate biosynthesis
L-lactate dehydrogenase 1.1.1.27 PF13 0141 22 Glycolysis
Enoyl-acyl carrier reductase 1.3.1.9 MAL6P 1.275 30 Fatty acid synthesis
2-oxoglutarate dehydrogenase el component 1.2.4.2 PF08_0045 30 TCA cycle
Lipoamide dehydrogenase, putative 1.8.1.4 PF08_0066 28 TCA cycle
Pyruvate dehydrogenase El component, ?-subunit 1.2.4.1 PF11_0256 28 Fatty acid synthesis
NADH-cytochrome b5 reductase 1.6.2.2 PF13_0353 32 Electron transport
Malate dehydrogenase, putative 1.1.1.37 MAL6P 1.242 34 Pyruvate metabolism
Glycerol-3-phosphate dehydrogenase 1.1.1.8 PF11 0157 PFL0780w 37 19 Glycolysis; Glycerol metabolism
GDP-mannose 4,6-dehydratase 1.1.1.187 PF08_0077 39 Mannose and fructose metabolism
Inosine-5 '-monophosphate dehydrogenase 1.1.1.205 PFI1020c 12 Purine metabolism
3-methyl-2-oxobutanoate dehydrogenase (lipoamide) 1.2.4.4 PFE0225w 32 Leucine, isoleucine and valine degradation
Nitrate reductase 1.7.1.1 chr13.glm_739 32 Nitrogen metabolismMalaria Journal 2005, 4:17 http://www.malariajournal.com/content/4/1/17
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Inspection of the time-dependent transcription of genes
coding enzymes that are involved in NAD(P)+ biosynthe-
sis reveal an unusual pattern. Transcriptional profiles of at
least three transcripts show two peaks, namely those of
nicotinamidase, of nicotinate-nucleotide adenylyltrans-
ferase and of NAD(P)+ transhydrogenase, as compared to
most other transcripts in the parasite transcriptome that
are monophasic. The reason for this pattern is unclear as
biochemical data are uanavilable for any physiological
intepretation, but it may suggest that the the enzymes are
not stable. Assuming that the first smaller peak of
nicotinate-nucleotide adenylyltransferase (20 HPI) is suf-
ficient for adequate expression of enzymatic activity, the
biosynthesis of NAD(P)+ should peak when NAD+ syn-
thetase is at its peak, i.e., at 28 HPI. Thus, by 28 HPI the
transcripts of all enzymes necessary for NAD+ synthesis are
fully deployed and somewhat later, synthesis itself is
probably fully deployed. This time pattern means that
important activities, such as glycolysis (the transcription
of genes coding for glycolytic enzymes starts to peak at 9
HPI and starts to decrease at 24 HPI [2] At earlier stages
glycolysis and PPP activity probably depend on the pool
of NAD(P)+ that were present in the invading merozoite.
For the full activation of glycolysis at the trophozoite stage
[28], the pool of NAD(P)+ has to be significantly ampli-
fied. As can be seen in Table 3, several genes coding for
enzymes requiring NAD(H) are transcribed earlier than
the complete transcription of genes related to NAD+ syn-
thesis. Such an outstanding exception is that of inosine-5'-
monophosphate dehydrogenase, an essential enzyme in
the purine metabolic pathway: it is transcribed too early to
allow its translated product to be functionally useful. The
functional meaning of the second peaks of nicotinami-
dase and of nicotinate-nucleotide adenylyltransferase is
enigmatic since the transcription of all other enzyme-cod-
ing genes declines to a minimum when they peak. For
being meaningful physiologically, the stability of all other
enzymes must be sustained with time. Indeed, it has been
recently shown that the levels of some proteins such as
methionine adenosyltransferase, ornithine aminotrans-
ferase, lactate dehydrogenase, glyceraldehyde 3-phos-
phate dehydrogenase and enolase, are not only increased
following transcription, but further increase after their
transcript levels decline [23]. Finally, NAD+  kinase is
essential for the production of NADP+. Its absence from
the genome is indeed very perplexing because biochemi-
cal evidence indicate that the parasite is able to synthesize
NADP+ [19] and the presence of many enzymes that need
it as a cofactor, implicate that its synthesis is essential for
parasite growth. As long as the gene (or some surrogate
mecahnism) is not identified, nothing can be said about
the coordination of NADP+ biosynthesis and the expres-
sion of enzymes that utilize it (Table 1).
Transhydrogenase operates at an important interface
between NAD(H) and NADP(H) and between the mito-
chondrial proton electrochemical gradient ??; [29]. Under
regular physiological conditions, the enzyme is a con-
sumer of ??:
NADH + NADP+ + H+
out_ NAD+ + NADPH + H+
in.
The energy of the gradient can drive the [NADPH][NAD+]/
[NADP+][NADH] ratio to values >400. Transhydrogena-
tion can also function in the reverse direction from
NADPH to NAD+. This is accompanied by outward
proton translocation and formation of ??. In this mode,
the enzyme utilizes substrate binding energy for proton
pumping. Therefore, in terms of energy transduction, the
transhydrogenase works in principle like the ATP synthase
complex of mitochondria, the proton ATPase. Given the
fact that the parasite genome does not have the full com-
plement of genes coding for the mitochondrial proton
ATPase [30], it is tempting to suggest that the transhydro-
genase could fulfill such role. The transcription of the
gene coding for transhydrogenase shows two very distinct
peaks at 20 and 30 HPI, with no detectable transcription
between them. It may well be that the second peak is
adjusted to the time of elongation and division of the sin-
gle mitochondrion [31].
Thiamine biosynthesis
The essential product of this pathway, thiamine diphos-
phate, is a cofactor of many enzymes (Table 4). The path-
way is shown in Figure 6 and the time-dependent
transcription of the different genes is depicted in Figure 7.
Thiamine (vitamin B1) is the precursor of the coenzyme
thiamine pyrophosphate that is involved in the action of
many decarboxylating enzymes and relevant to the
present analysis, in the function of transketolase. P.
berghei-infected erythrocytes contain higher levels of
thiamine than their uninfected counterparts [32] and thi-
amine deficiency retards the propagation of this parasite
in vivo [33]. The incidence of thiamine deficiency in adults
admitted to hospital with malaria in Thailand has been
examined [34] and it was observed that in hospitalized
thiamine deficiency commonly complicates acute
falciparum malaria, particularly in severe infections, and
could contribute to dysfunction of the central nervous sys-
tem. Thiamine could be obtained by the parasite from the
extracellular space (like in animal cells) and pyrophos-
phorylated by thiamine diphosphokinase (EC: 2.7.6.2).
However the presence of genes coding for enzymes that
participate in the eukaryote biosynthetic pathway of thia-
mine phosphate, suggest that the parasite is able to
synthesize its own precursor. Nevertheless, the absence of
a gene coding for thiamine phosphate kinase (EC:
2.7.4.16) must be resolved and direct biochemical dem-
onstration of activity must be performed before a firmMalaria Journal 2005, 4:17 http://www.malariajournal.com/content/4/1/17
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Biosynthesis of thiamine diphosphate Figure 6
Biosynthesis of thiamine diphosphate. The no entry symbol indicates that the gene coding for this enzyme could not be 
found in the genome of P. falciparum. No biochemical evidence exists to confirm or refute enzyme activity. It has been added to 
the scheme because genes coding for enzymes preceding it in the pathway are present in the genome.
Table 4: Thiamine diphosphate utilizing enzymes. Enzymes are arranged by their sequential functional order. They are given by their 
name, their EC numbers, the gene identification (PfID) in the Plasmodium genome database (PlasmoDB), the time (in hours post 
invasion (HPI)) in the parasite's developmental cycle when they are maximally transcribed obtained from the IDC database, the 
metabolic function of the enzyme.
Enzyme EC number PfID HPI Metabolic function
Pyruvate dehydrogenase E1 1.2.4.1 PF11_0256 (a)
PF14_0441 (b)
28
28
Apicoplast fatty acid synthesis
Transketolase 2.2.1.1 MAL6P1.110 17 Pentose phosphate pathway
Oxalyl-CoA decarboxylase 4.1.18 MAL6P1.231
PFF0945c
26
NA
Glyoxylate and dicarboxylate metabolism
1-deoxy-D-xylulose-5-phosphate synthase 2.2.1.7 PF13_0207 21 Isoprenoid biosynthesis
3-methyl-2-oxobutanoate dehydrogenase 1.2.4.4 PFE0225w 32 Leucine, isoleucine and valine degradation
Oxoglutarate dehydrogenase 1.2.4.2 PF08_0045 32 Mitochondrial TCA cycle
4-amino-5-hydroxymethyl-2-methylpyrimidine
1-(5’-phosphoribosyl)-5-aminoimidazole
4-amino-2-methyl-5-phosphomethylpyrimidine
2-methyl-4-amino-5-hydroxymethyllpyrimidine-2P
D-Glyceraldehyde-3P Pyruvate
5-(2-hydroxyethyl)-4-methylthiazole
4-methyl-5-(2-phosphoethyl)-thiazole
Thiamine phosphate
Thiamine diphosphate Thiamine
Thiamine diphosphokinase
ATP
ADP
ATP
ADP
ATP
ADP
ATP
ADP
ATP
ADP
ATP
ADP
ATP
ADP
Hydroxyethylthiazole kinase
Hydroxymethylpyrimidine kinase
Phosphomethylpyrimidine kinase
PPi
Thiamine-phosphate pyrophosphorylase
ATP AMP
Thiamine-phosphate kinase
Involved in enzymatic activity of:
Pruvate decarboxylase
Pyruvate dehydrogenase
α-ketoglutarate dehydrogenase
Transketolase
ATP ADP
Thiamine triphosphate
Thiamine diphosphokinase
Purine Purine metabolism metabolism
Glycolysis Glycolysis
From From extracellular extracellular medium mediumMalaria Journal 2005, 4:17 http://www.malariajournal.com/content/4/1/17
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statement can be made on this metabolic pathway. It is
not unlikely that thiamine phosphate kinase is not
needed, as is the situation in yeast [35]. There it is sug-
gested that thiamine phosphate is hydrolyzed to thiamine
by a non-specific phosphatase and thiamine is then con-
verted to thiamine pyrophosphate by thiamine
diphosphokinase.
The transcription of all genes coding for enzymes involved
in thiamine pyrophosphate seems to be coordinated, sin-
gle phased and peaking between 20 and 30 HPI. If thia-
mine is obtained from the host and thiamine
pyrophosphate is synthesized by the single step mediated
by thiamine diphosphokinase, the peak transcription of
this gene at 28 HPI lags by several hours after that of tran-
sketolase (17 HPI), but since transketoalse is not the
expression time-setter of PPP, this lag does not seem to
limit the full activity of PPP. However, if most of the thia-
mine is generated endogenously by the parasite, the
supply of this precursor will peak only at 33 HPI, thus lim-
iting full PPP activity. It is not unlikely that both processes
occur in tandem or that at advanced stage of parasite
development, the need for thiamine cannot be met any-
more by exogenous supply and the endogenous synthesis
joins the game.
Conclusion
The analysis of time-dependence transcription of parasite
genes concluded that the parasite has evolved a highly
specialized mode of transcriptional regulation that
produces a continuous cascade of gene expression, begin-
ning with genes corresponding to general cellular proc-
esses, such as protein synthesis, and ending with
Plasmodium-specific functionalities, such as genes
involved in erythrocyte invasion [2]. However, a meticu-
lous analysis shows marked and important deviations
from this prototype that reveal a lack of coordinated tran-
scription of genes coding for enzymes of the same meta-
bolic pathway and between pathways. There are three
most straightforward explanations for these apparent dis-
crepancies. First, there are additional enzymes facilitating
the "missing" activities and their identity was not revealed
by the present annotations due to their diverse amino acid
sequence. Second, the misaligned transcriptional regula-
tion reflect an intricate interplay of the biosynthetic path-
ways where delayed production of metabolites in one
pathway functions as a rate limiting factor for other path-
way, which is otherwise fully deployed. Last but not least,
post-transcriptional regulation may also play a role. All
theories create an intriguing possibility for further studies.
Clearly this effort will be enhanced by substantial progress
in proteomics and most importantly, direct biochemical
demonstrations of activities of individual enzymes and
entire pathways.
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